iLite® assays for the quantification of the potency and neutralizing antibody response to recombinant AAV vectors

Time: 1:00 pm
day: Track A - Day 1 PM

Details:

  • Highly sensitive assays, with an extended dynamic range,
    have been developed based on the iLite® reporter-gene
    technology for the quantification of the potency of AAV
    encoded transgenes regulated by photoreceptor-specific
    promoters without the need for helper virus or proteosome
    inhibitors.
  • A highly sensitive, rapid, and serotype specific assay for the
    quantification of neutralizing antibodies to recombinant
    AAV vectors based on the iLite® technology will also be
    presented

Speakers: